Enanta Pharmaceuticals Inc (ENTA) SEC Filings — 2025
15 SEC filings for Enanta Pharmaceuticals Inc (ENTA) in 2025.
Filings
- Enanta Shifts Royalty Focus, Eyes RSV & Immunology Growth Amid Losses — 10-K · Nov 19, 2025
- Enanta Pharmaceuticals Inc 8-K Filing — 8-K · Nov 17, 2025
- Enanta Pharmaceuticals Files 8-K — 8-K · Oct 1, 2025
- Enanta Pharmaceuticals Files 8-K Report — 8-K · Sep 29, 2025
- Enanta Pharmaceuticals Announces Executive and Director Changes — 8-K · Aug 27, 2025
- Enanta Pharmaceuticals Files 8-K — 8-K · Aug 20, 2025
- Enanta Narrows Q3 Loss Amidst Reduced R&D Spending — 10-Q · Aug 13, 2025
- Enanta Pharmaceuticals Files 8-K on Financials — 8-K · Aug 11, 2025
- Enanta Pharma Q2 2025 Update: Royalty Deal Highlighted — 10-Q · May 14, 2025
- Enanta Pharmaceuticals Files 8-K — 8-K · May 12, 2025
- Enanta Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Mar 17, 2025
- Enanta Pharma Q1 2025 Update: Financials and Equity Awards — 10-Q · Feb 12, 2025
- Enanta Pharmaceuticals Files 8-K on Financials — 8-K · Feb 10, 2025
- Enanta Pharma Files Additional Proxy Materials — DEFA14A · Jan 27, 2025
- Enanta Pharma DEF 14A: Executive Compensation Details — DEF 14A · Jan 27, 2025